Squamous Cell Carcinoma of the Head and Neck

Hypofractionated Radiotherapy in Older Adults With Head and Neck Squamous Cell Carcinoma

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

CIML NK Cell in Head & Neck Cancer

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck

Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors